About Amy Bohnert, Ph.D., M.H.S.

Dr. Bohnert’s research focuses on prescription drug overdose and interventions regarding substance use and related disorders, including brief motivational interventions to improve safe use of opioids among VA patients and to reduce overdose risk among individuals in residential addictions treatment. She has led a number of projects related to overdose and prescription drug safety, many aimed at improving care occurring in substance use disorder treatment settings. She is also working on analyses of medical records data linked to mortality data in order to improve prescribing practices. She has provided scientific guidance to the Governor's Prescription Drug and Opioid Abuse Task Force (MI) and is a member of the core expert group that provided guidance to the CDC in developing its opioid prescribing guidelines for chronic pain. She co-directs the Mental Health Innovation, Services and Outcomes Program (MHISO) within the U-M Department of Psychiatry. Dr. Bohnert also serves as a member of IHPI’s Early Career Faculty Advisory Council (ECFAC).

What You'll Learn

• What is the “spectrum of intent” of opioid overdoses?
 
• What is the correlation between opioid prescription and opioid overdose?
•  
• What populations are most at risk of opioid abuse?
 
• How can we determine precisely when someone has an opioid misuse disorder? How do we identify addiction?
 
• How can Medication-Assisted Therapy be used to successfully treat opioid misuse?
 
• How should we talk to friends and family who may be misusing opioids?